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Acetylation is one of the most abundant post-
translational modifications in biology and is conserved
in all kingdoms of life. As many as 90% of proteins
involved in Salmonella enterica metabolic pathways
are acetylated [1], primarily at lysine residues, and
more than 80% of human proteins are N-terminally
acetylated [2]. Analogous to phosphorylation, attach-
ment of an acetyl group to a protein amino acid is a
reversible reaction catalyzed by dedicated enzymes
that have acetyl-transferase or deacetylase activity.
Perhaps themostwidely studied andbest documented
example of acetylation affects histones, basic proteins
tightly bound to DNA to form chromatin. Acetylation of
critical lysines in histone tails decreases the overall
positive charge, decreasing electrostatic interactions
with DNA [3]. This is thought to promote chromatin
decondensation and to enhance accessibility to RNA
polymerase, thereby stimulating transcriptional activi-
ty. On the contrary, histone deacetylation is usually
associated with a reduction of transcriptional activity.
Thus, protein acetylation represents a versatile and
reversible molecular switch of vital importance in
biology.SirtuinsAreUbiquitousNAD+-Dependent
Deacetylases
There are four classes of histone deacetylases
(HDAC) in eukaryotes, of which sirtuins (or class III)
are highly conserved phylogenetically. One of the
defining characteristics of sirtuins is the requirement
of NAD+ as cofactor [4], a dependence that links
sirtuin function to themetabolic state of the cell. Caloric
restriction studies in yeast, worms and flies have
shown increased longevity linked to the increasedatter © 2013 The Authors. Published by Elactivity of homologs of the Saccharomyces cerevisiae
founder sirtuin, Sir2 [4,5]. The human genome
encodes seven sirtuins, named SIRT1–SIRT7 [5].
SIRT1 (also known as Sir2α) is the closest homolog of
yeast Sir2, and as in this model organism, its activity is
also increased due to caloric restriction [6,7]. SIRT1
has many important cellular targets, such as p53 [8],
NF-κB [9], FOXO [10] and PPARγ [11], making it an
attractive target for cancer therapeutics and longevity
studies. At the structural level, all sirtuins have a
conserved catalytic core composed of a Rossmann
fold for NAD+ binding, a Zn2+ binding module and a
helical module containing an NAD+-binding loop.
NAD+ and the acetylated lysine substrate bind across
this interface, with the acetylated ε-amino group of the
lysine adjacent to the ribose moiety of NAD+, in a
hydrophobic tunnel where catalysis occurs. The
substrate is primarily bound by backbone interactions
and the formation of a three-stranded antiparallel
“β-staple”. Physiological acetyl-peptides are accom-
modated in SIRT1 active site mainly by hydrogen
bonding with their main-chain backbone, allowing
deacetylation without sequence conservation [12].
There appears to be no particular consensus
sequence for substrate binding to sirtuins, but
specificity is dependent on the amino acid context
of the acetylated lysine [12,13]. After catalysis, the
products of this reaction are 2′-O-acetyl-ADP-ribose
(OAADPr), nicotinamide and the deacetylated
substrate.Regulation of Human SIRT1 by Its
C-Terminal Regulatory Segment
In addition to the conserved catalytic core, located
from residue 230 to residue 500, SIRT1 also
presents N- and C-terminal extensions found in no
other human sirtuin, which are thought to play asevier Ltd. All rights reserved. J. Mol. Biol. (2014) 426, 507–509
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stretch at the C-terminus of murine SIRT1 (residues
631–655) that is essential for deacetylase activity [14]
and that competes with an endogenous inhibitory
factor known as DBC1 (Deleted in Breast Cancer-1)
for activation of SIRT1 catalytic core (SIRT1CAT) [15].
Theyproposed thatSIRT1C-terminal regulatory (CTR)
region (SIRT1CTR) functions allosterically to alter the
affinity of the catalytic core for the acetylated substrate.
Concurrently, Pan et al. found that SIRT1CAT has very
low enzymatic activity on its own and that both the N-
and C-term regions are able to enhance SIRT1CAT
activity [16]. They proposed that the N-terminal
domain increases the rate of catalysis, while the
C-terminal domain (residues 584–665) increases
binding to NAD+ and can function in trans. In this
issue of the Journal of Molecular Biology, Davenport
et al. report two crystal structures of human SIRT1
catalytic domain bound to its CTR (residues 641–
665), crystallized in the presence (closed state) and in
the absence (open state) of cofactor NAD+ [17].
Unexpectedly, the authors identified a dramatic
conformational change between the two states.
Without NAD+ (which is reacted in crystal to generate
adenosine diphosphatase ribose), SIRT1 adopts an
open conformation with the Zn2+ binding and helical
modules rotated with respect to the NAD+-binding
domain. In the presence of cofactor, the SIRT1 helical
module is tightly folded onto the catalytic domain,
adopting a closed conformation. Davenport et al.
showed that interaction between SIRT1CAT and the
CTRgreatly stabilizes the catalytic core, which is quite
unstable at 37 °C (the temperature at which most
enzymatic studies are performed). This structural
stabilization does not increase enzymatic activity but
rather dampens SIRT1 activity in vitro. However,
removing the last 12 residues of the CTR or disrupting
a conserved salt bridge between residues R276 and
E656 relieves this attenuation and increases SIRT1
activity. This begs the question as to whether the CTR
regulates deacetylase activity only intramolecularly (in
cis) or if a more complex intermolecular mechanism of
trans-activation occurs in solution, as previously
suggested [16]. The authors explore both alternatives,
although a conclusive answer will require more
extensive investigations in vivo. In solution, an excess
of CTR can compete off bound CTR and form a
complex with SIRT1CAT that co-migrates on a gel-
filtration column and the SIRT1CAT and CTR were
co-crystallized, suggesting a binding affinity at least in
the micromolar range. However, an accurate dissoci-
ation constant between SIRT1CAT and CTR could not
be determined due to the tendency of SIRT1CAT to
aggregate in solution. To complicate the puzzle, the
authors also identified a substrate-mimetic peptide
projecting from C-terminal residues 504–510 of a
crystallographic mate “stapled” inside SIRT1 active
site. The backbone conformation adopted by this
pseudo-substrate is superimposable to the p53substrate peptide (HKKAcLMF) previously analyzed
in complex with an archaeal SIRT1 ortholog [18]. A
unique leucine in the pseudo-substrate occupies
the position of the substrate acetyl-lysine directly
facingNAD+. This suggests that various regions in the
regulatory domains could potentially occupy the
substrate-binding pocket and auto-inhibit the enzyme,
reconciling the observation that the isolatedSIRT1CAT
is essentially inactive in vitro [16]. Although not directly
shown in this paper, we speculate that binding of
a CTR to SIRT1CAT in the presence of N-terminal
regulatory and CTR domains may contribute to
removing a pseudo-substrate from the active site,
stimulating catalytic activity.Perspectives and Future Directions
The studies of Davenport et al. provide structural
evidence for a regulatory role of SIRT1 C-terminal
domain on deacetylase activity. This includes not
only the previously identified CTR but also the
C-terminal pseudo-substrate spanning region 504–
510 that occupies the cargo-binding groove. Building
upon this work, it is foreseeable that at least two
directions of research will be particularly interesting
to explore. First, to delve into the exact regulatory
role of SIRT1CTR, it is essential to study its properties
in a physiological environment. Phosphorylation in the
CTR [19] is likely to play a pivotal role in modulating
the interplay between potential intramolecular auto-
inhibition by pseudo-substrate moieties and availabil-
ity of acetylated substrates and hence promote
temporal and spatial control of deacetylase activity.
Second, as elegantly suggested by this paper, the
observation that a leucine side chain can functionally
replace the side chain of an acetyl-lysine provides a
powerful framework to engineer peptides (or peptide-
mimetics) that could compete with acetyl-substrates
and inhibit SIRT1 activity. Given the broad physiolog-
ical importance of acetylation and the pivotal role of
acetylation in turning genes on and off, potent and
selective small molecules to modulate SIRT1 activity
would be at the forefront of fighting cancer and
metastatic proliferation.References
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